Pulmonary embolism最新文献_第5页

Covid-19 and pulmonary embolism : A heterogeneous association Covid-19与肺栓塞:异质性关联

Pulmonary embolism Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa502

Khalil Bahri, S. Mhamdi, S. Daboussi, Asma Riahi, Imen Yousfi, I. Mejri, C. Aichaouia, Ziad Moatamri, M. Khadhraoui

引用次数: 0

Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism 急性和稳定型肺栓塞急性期反应物戊曲辛-3与炎症参数的比较

Pulmonary embolism Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa510

Asiye Büşra Çimen, A. F. Kalpaklioglu

引用次数: 0

The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism 尿酸/肌酐比值作为肺栓塞预测指标的作用

Pulmonary embolism Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa2591

K. Bartziokas, C. Kyriakopoulos, A. Gogali, Dimitrios Potonos, K. Exarchos, C. Chronis, K. Kostikas

引用次数: 0

Prevalence and characteristics of venous thromboembolism in severe exacerbation of COPD in a tertiary care hospital in India 在印度三级医院的严重加重COPD静脉血栓栓塞的患病率和特点

Pulmonary embolism Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa500

S. Meitei, S. Tale, A. Negi, R. Dua, R. Walia, S. Saxena

引用次数: 0

Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome 预测住院时间和肺栓塞结局的生物标志物模型

Pulmonary embolism Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa504

C. Kyriakopoulos, K. Bartziokas, A. Gogali, K. Tatsis, C. Chronis, Dimitrios Potonos, G. Gkrepi, K. Kostikas

引用次数: 0

Retrospective application of the YEARS algorithm to an ambulatory PE clinic cohort YEARS算法在体育门诊队列中的回顾性应用

Pulmonary embolism Pub Date : 2020-09-07 DOI: 10.1183/13993003.congress-2020.4976

S. Toor, H. McAuley, R. Spriggs, E. Bailie, N. Parmar, N. Greening

{"title":"Retrospective application of the YEARS algorithm to an ambulatory PE clinic cohort","authors":"S. Toor, H. McAuley, R. Spriggs, E. Bailie, N. Parmar, N. Greening","doi":"10.1183/13993003.congress-2020.4976","DOIUrl":"https://doi.org/10.1183/13993003.congress-2020.4976","url":null,"abstract":"Background: Despite routine use of the Wells score and D-Dimers (DD), high proportions of CTPAs are negative, increasing unnecessary exposure to the risks of CT contrast and radiation. Variable presentation and high perceived risk of missed PEs makes risk stratification complex. The YEARS algorithm offers a more specific tool to reduce the number of CTPAs performed without increased risk. Methods: This audit applied the YEARS algorithm to ambulatory patients who had undergone CTPA for suspected PE, treated based on Wells score and DD. Patients were stratified as either high or low risk by the presence of any one of the YEARS items: clinical signs of DVT, PE the most likely diagnosis, haemoptysis. DD cut offs for ruling out PE were applied: ≤500 ng/mL for high risk and ≤1000 ng/mL for low risk. The outcome measures were the number of positive CTPAs missed and the number of CTPAs avoided. Results: 1527 events were reviewed with 485 (32%) included in our analysis. Detailed findings are shown in figure 1. Two CTPAs (0.4% of scans) were positive for PE, which may not have been performed using the YEARS algorithm (one sub-segmental PE and one PE with atypical history and borderline DD of 990 ng/mL). Application of the YEARS algorithm would have avoided 121 (25%) of all CTPAs. Conclusion: In this audit, application of the YEARS algorithm potentially reduced CTPAs by 25% without significant increased risk.","PeriodicalId":20797,"journal":{"name":"Pulmonary embolism","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83621038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis 直接口服抗凝剂和低分子肝素用于癌症患者静脉血栓栓塞的一级预防:一项荟萃分析

Pulmonary embolism Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6045

Anna Francesca Mulles, Amraphel Nicolas, H. H. Chiu, R. E. Villalobos

{"title":"Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis","authors":"Anna Francesca Mulles, Amraphel Nicolas, H. H. Chiu, R. E. Villalobos","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6045","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6045","url":null,"abstract":"Background: Venous thromboembolism (VTE) is a serious complication among cancer patients necessitating hospitalization. Current guidelines recommend anticoagulation using low molecular weight heparins (LMWH) for prevention of VTE. Recent studies have also demonstrated the efficacy of direct oral anticoagulants (DOACs) in the prevention of VTE among cancer patients. We aimed to assess the efficacy of DOACs and LMWH in primary prevention of VTE among cancer patients, and evaluate the risks of bleeding. Methods: Electronic databases were searched for randomized trials evaluating LMWH and DOACs versus placebo as primary prevention for VTE among cancer patients. The primary outcomes were VTE events and incidence of major and minor bleeding. Studies were assessed using the Cochrane Handbook for Systematic Reviews of Interventions. Results were calculated via RevMan Version 5.3 using fixed-effect modelling. Results: Seven randomized trials (two on DOACs; five on LMWHs) with 7073 patients were included. Both DOACs [RR 0.57; 95% CI 0.38, 0.84, p = 0.004] and LMWH [RR 0.49; CI 95% 0.36, 0.65, p Conclusion: Both DOACs and LMWH are effective in the prevention of VTE among cancer patients without an increase in risk for major bleeding. Compared to LMWH, DOAC may be associated with decreased risk of major bleeding.","PeriodicalId":20797,"journal":{"name":"Pulmonary embolism","volume":"361 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83130479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

PE Diagnosis

Pulmonary embolism Pub Date : 2020-01-01 DOI: 10.1007/978-3-030-51736-6_2

S. Naydenov, A. Ho

引用次数: 0

Endovascular Techniques in the Treatment of Acute PE 血管内技术治疗急性肺动脉栓塞

Pulmonary embolism Pub Date : 2020-01-01 DOI: 10.1007/978-3-030-51736-6_7

P. Guichet, A. Sista

引用次数: 0

Pulmonary Embolism: From Acute PE to Chronic Complications 肺栓塞:从急性肺栓塞到慢性并发症

Pulmonary embolism Pub Date : 2020-01-01 DOI: 10.1007/978-3-030-51736-6

B. Rivera-Lebron, G. Heresi

引用次数: 0